Aditxt, Inc. Stockholders' Equity Note, Changes in Capital Structure, Subsequent Changes to Number of Common Shares
Aditxt, Inc. (ADTX) had Stockholders' Equity Note, Changes in Capital Structure, Subsequent Changes to Number of Common Shares of 1.5 shares as of 2021-08-31, per its 10-K filed 2022-03-31.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares · last filed 2025-11-18
- 2021-08-31: Stockholders' Equity Note, Changes in Capital Structure, Subsequent Changes to Number of Common Shares 1.50 shares.
- 2021-02-24: Stockholders' Equity Note, Changes in Capital Structure, Subsequent Changes to Number of Common Shares 12.50K shares.
| Period end | Stockholders' Equity Note, Changes in Capital Structure, Subsequent Changes to Number of Common Shares |
|---|---|
| 2021-08-31 | 1.50 shares 10-K · filed 2022-03-31 |
| 2021-02-24 | 12.50K shares 10-Q · filed 2025-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |